| Ident. | Authors (with country if any) | Title |
|---|
| 000021 (2011) |
Wassilios Meissner [France] ; Mark Frasier [États-Unis] ; Thomas Gasser [Allemagne] ; Christopher Goetz [États-Unis] ; Andres Lozano [Canada] ; Paola Piccini [Royaume-Uni] ; José Obeso [Espagne] ; Olivier Rascol [France] ; Anthony Schapira [Royaume-Uni] ; Valerie Voon [Royaume-Uni] ; David Weiner [États-Unis] ; François Tison [France] ; Erwan Bezard [France] | Priorities in Parkinson's disease research |
| 000037 (2009) |
Suzanne Lesage [France] ; Alexis Brice [France] | Parkinson's disease: from monogenic forms to genetic susceptibility factors |
| 000043 (2010) |
Patrice Pran [Italie, France] ; Andrea Cherubini [Italie] ; Francesca Assogna [Italie] ; Fabrizio Piras [Italie] ; Carlo Quattrocchi [Italie] ; Antonella Peppe [Italie] ; Pierre Celsis [France] ; Olivier Rascol [France] ; Jean Dmonet [France] ; Alessandro Stefani [Italie] ; Mariangela Pierantozzi [Italie] ; Francesco Pontieri [Italie] ; Carlo Caltagirone [Italie] ; Gianfranco Spalletta [Italie] ; Umberto Sabatini [Italie] | Magnetic resonance imaging markers of Parkinsons disease nigrostriatal signature |
| 000098 (2009) |
A Schapira [Royaume-Uni] ; Y Agid [France] ; P Barone [Italie] ; P Jenner [Royaume-Uni] ; M Lemke [Allemagne] ; W Poewe [Autriche] ; O Rascol [France] ; H Reichmann [Allemagne] ; E Tolosa [Espagne] | Perspectives on recent advances in the understanding and treatment of Parkinson’s disease |
| 000119 (2008) |
C Olanow [États-Unis] ; Robert Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000123 (2011) |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
| 000127 (2010) |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony Lang [Canada] ; C Olanow [Italie, États-Unis] | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
| 000133 (2009) |
M Ferraye [France] ; B Deb [France] ; V Fraix [France] ; L Goetz [France] ; C Ardouin [France] ; J Yelnik [France] ; C Henry [France] ; E Seigneuret [France] ; B Piallat [France] ; P Krack [France] ; J Le [France] ; A Benabid [France] ; S Chabards [France] ; P Pollak [France] | Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease |
| 000174 (2006) |
M Horstink [Pays-Bas] ; E Tolosa [Espagne] ; U Bonuccelli [Italie] ; G Deuschl [Allemagne] ; A Friedman [Pologne] ; P Kanovsky [République tchèque] ; J Larsen [Norvège] ; A Lees [Royaume-Uni] ; W Oertel [Allemagne] ; W Poewe [Autriche] ; O Rascol [France] ; C Sampaio [Portugal] | Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease |
| 000175 (2010) |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert Hauser [États-Unis] ; Anthony Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge Van [Pays-Bas] ; Guus Van [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 000180 (2010) |
Suzanne Lesage ; Etienne Patin ; Christel Condroyer ; Anne Leutenegger ; Ebba Lohmann ; Nir Giladi ; Anat Bar ; Soraya Belarbi ; Nassima Hecham ; Pierre Pollak ; Anne Ouvrard ; Soraya Bardien ; Jonathan Carr ; Traki Benhassine ; Hiroyuki Tomiyama ; Caroline Pirkevi ; Tarik Hamadouche ; Ccile Cazeneuve [France] ; A Basak ; Nobutaka Hattori ; Alexandra Drr [France] ; Meriem Tazir ; Avi Orr ; Lluis Quintana ; Alexis Brice [France] ; Y Agid ; A Bonnet ; M Borg ; A Brice ; E Broussolle ; Ph Damier ; A Deste ; A Drr ; F Durif ; E Lohmann ; M Martinez ; C Penet ; P Pollak ; O Rascol ; F Tison ; C Tranchant ; A Troiano ; M Vrin ; F Viallet ; M Vidailhet | Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans |
| 000193 (2010) |
Joaquim Ferreira [Portugal] ; Dulce Neutel [Portugal] ; Tiago Mestre [Portugal] ; Miguel Coelho [Portugal] ; Mário Rosa [Portugal] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Skin cancer and Parkinson's disease |
| 000213 (2010) |
Sandra Thier [Allemagne] ; Delia Lorenz [Allemagne] ; Michael Nothnagel [Allemagne] ; Giovanni Stevanin [France] ; Alexandra Dürr [France] ; Almut Nebel [Allemagne] ; Stefan Schreiber [Allemagne] ; Gregor Kuhlenb [Allemagne] ; Günther Deuschl [Allemagne] ; Stephan Klebe [Allemagne] | LINGO1 polymorphisms are associated with essential tremor in Europeans |
| 000233 (2008) |
Christopher Goetz [États-Unis] ; Murat Emre [Turquie] ; Bruno Dubois [France] | Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis |
| 000242 (2008) |
Hubert Fernandez [États-Unis] ; Dag Aarsland [Norvège] ; Gilles Fénelon [France] ; Joseph Friedman [États-Unis] ; Laura Marsh [États-Unis] ; Alexander Tröster [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn Stebbins [États-Unis] ; Christopher Goetz [États-Unis] | Scales to assess psychosis in Parkinson's disease: Critique and recommendations |
| 000248 (2001) |
Patricia Dowsey [Royaume-Uni] ; Pierre Pollak [France] | Deep brain stimulation in the treatment of Parkinson's disease: a review and update |
| 000252 (2001) |
S. Thobois [France] ; S. Guillouet [France] ; E. Broussolle [France] | Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson’s disease |
| 000282 (2006) |
M Horstink [Pays-Bas] ; E Tolosa [Espagne] ; U Bonuccelli [Italie] ; G Deuschl [Allemagne] ; A Friedman [Pologne] ; P Kanovsky [République tchèque] ; J Larsen [Norvège] ; A Lees [Royaume-Uni] ; W Oertel [Allemagne] ; W Poewe [Autriche] ; O Rascol [France] ; C Sampaio [Portugal] | Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease |
| 000334 (2010) |
David Devos [France] ; L Defebvre [France] ; R Bordet [France] | Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease |
| 000349 (2009) |
S. Bannier [France] ; C. Montaurier [France] ; P Derost [France] ; M. Ulla [France] ; J Lemaire [France] ; Y. Boirie [France] ; B. Morio [France] ; F. Durif [France] | Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up |
| 000351 (2011) |
Jean Corvol [France] ; Cécilia Bonnet [France] ; Fanny Charbonnier [France] ; Anne Bonnet [France] ; Marie Fiévet ; Agnès Bellanger ; Emmanuel Roze [France] ; Gayané Meliksetyan [France] ; Mouna Ben [France] ; Andreas Hartmann [France] ; Lucette Lacomblez [France] ; Cédric Vrignaud [France] ; Noël Zahr [France] ; Yves Agid [France] ; Jean Costentin [France] ; Jean Hulot [France] ; Marie Vidailhet [France] | The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial |
